Zobrazeno 1 - 3
of 3
pro vyhledávání: '"David Humberto Marmolejo Castañeda"'
Autor:
Kreina Sharela Vega Cano, David Humberto Marmolejo Castañeda, Santiago Escrivá-de-Romaní, Cristina Saura
Publikováno v:
Cancers, Vol 15, Iss 1, p 51 (2022)
Approximately 20% of breast cancers (BC) overexpress human epidermal growth factor receptor 2 (HER2). This subtype of BC is a clinically and biologically heterogeneous disease that was associated with an increased risk for the development of systemic
Externí odkaz:
https://doaj.org/article/81572b009d8a48b199650ffb1614c34e
Autor:
David Humberto Marmolejo Castañeda, Mara Cruellas Lapeña, Estela Carrasco López, Gloria Aparicio Español, Claudia Valverde Morales, Adrià López-Fernández, Eduard Pérez Ballesteros, Sara Torres-Esquius, Mónica Pardo Muñoz, Judith Balmaña Gelpi
Publikováno v:
Familial Cancer. 22:99-102
Rothmund-Thomson syndrome, a heterogeneous genodermatosis with autosomal recessive hereditary pattern, is an uncommon cancer susceptibility genetic syndrome. To date, only 400 cases have been reported in the literature, and the severity of the featur
Autor:
David Humberto Marmolejo Castañeda, Alex Martinez-Marti, Caterina Carbonell, Juan David Assaf Pastrana, Julia Lostes, A. Pedrola, Ramon Amat, N. Pardo, Susana Cedres Perez, Javier Gonzalo, A. Callejo, Rodrigo Dienstmann, Alejandro Navarro, Enriqueta Felip, P. Iranzo, Joan Frigola
Publikováno v:
Journal of Clinical Oncology. 39:e20563-e20563
e20563 Background: MPM is a highly aggressive pleural tumor associated with asbestos exposure and with limited survival despite systemic therapy. Histology is a prognostic factor and recently CheckMate 743 trial demonstrated survival benefit of immun